TNFR2 is required for RIP1-dependent cell death in human leukemia
Júlia Aguadé-Gorgorió(University of California, Los Angeles), Beat Bornhäuser(University Children's Hospital Zurich), Caterina Mezzatesta(University Children's Hospital Zurich), Martin Schrappe(University Hospital Schleswig-Holstein), Scott McComb(University of Ottawa), Blerim Marovca(University Children's Hospital Zurich), Silvia Jenni(University Children's Hospital Zurich), Maria Pamela Dobay(Biogen (Switzerland)), Gunnar Cario, Jean‐Pierre Bourquin(University Children's Hospital Zurich), Liridon Abduli(University Children's Hospital Zurich), Arend von Stackelberg(Charité - Universitätsmedizin Berlin), Anna Guinot(University Children's Hospital Zurich), Cornelia Eckert(Humboldt-Universität zu Berlin), Martin Stanulla(Leibniz University Hannover)
Cited by 12
Related Papers
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
|The Lancet|1998|964